You are a Pharma, Biotech or MedTech company with one (or more) product(s) in development, but your Regulatory pathway is not clear yet? This webinar is for you!
During this workshop, DDR's CEO Xavier Luria, former Head and Safety and Efficacy of Medicines at the European Medicines Agency (EMA) will share the essentials of Regulatory journeys in Europe.
In the first instance, Dr Luria will define the several categories of medicinal products and health technologies that can be marketed in Europe. Then, for each group -Drugs, Medical Devices and In Vitro Diagnostics- DDR will explain the main considerations to keep in mind when initiating your product development. At the end of the event, participants will also have the possibility to ask their questions to Dr Luria during a short Q&A session.
This 1-hour webinar is an opportunity for participants to understand the principal Regulatory requisites from the European Agencies with a view to avoid common mistakes during the development process.
About DDR: Drug Development and Regulation (DDR) is an independent European consultancy company, focused in providing appropriate scientific & regulatory expertise for the global development and registration of Drugs and Medical Devices.
Our valuable and tailor-made solutions contribute to the success of your development programs from a quality, nonclinical, clinical, and regulatory point of view.
Advantageously located in Barcelona, Amsterdam & London, DDR also benefits from a large network of highly qualified experts and strategic collaborations with renowned institutions worldwide.
Monday, May 03rd 2021
17:00 – 18:30 (CET)